Mateon Therapeutics Inc (MATN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting agents. It is developing a product for treatment of anaplastic thyroid cancer, medullary thyroid cancer, stage IV papillary thyroid cancer, ovarian cancer, stage IV follicular thyroid cancer, and others. Mateon offers development pipeline such as CA4P and Oxi4503. The company also conducts multiple clinical trials in oncology to discover small-molecule anticancer agents belong to benzosuberene class of compound. It operates through researchers in the University of Florida and the University of Arhus on anti-angiogenic and anti-metastatic agents. Oxigene is headquartered in South San Francisco, California, the US.

Mateon Therapeutics Inc (MATN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mateon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
OXiGENE Enters Into Licensing Agreement With Angiogene Pharma For Neuroendocrine Tumors 11
Equity Offering 13
Mateon Therapeutics Files Registration Statement for Public Offering of Shares 13
Mateon Therapeutics Raises USD2.9 Million in Private Placement of Shares 14
Mateon Therapeutics Plans to Raise Funds trough Public Offering of Shares and Warrants 15
Oxigene Raises USD10 Million in Private Placement of Units 16
Oxigene Raises USD12 Million in Public Offering of Unit 18
Oxigene Completes Private Placement Of Preferred Stock For US$5.8 Million 20
Oxigene Raises USD5 Million in Private Placement of Shares 21
Oxigene Completes Private Placement Of Shares For US$1.7 Million 22
Mateon Therapeutics Inc - Key Competitors 23
Mateon Therapeutics Inc - Key Employees 24
Mateon Therapeutics Inc - Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
May 14, 2018: Mateon Therapeutics Reports First Quarter 2018 Financial Results 26
Apr 16, 2018: Mateon Therapeutics Reports 2017 Financial Results 27
Nov 14, 2017: Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results 29
Aug 02, 2017: Mateon Provides Corporate Update and Reports Second Quarter 2017 Financial Results 30
May 08, 2017: Mateon Provides Corporate Update and Reports First Quarter 2017 Financial Results 31
Mar 30, 2017: Mateon Therapeutics Reviews 2016 Highlights and Reports 2016 Financial Results 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables

List of Tables
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mateon Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Mateon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OXiGENE Enters Into Licensing Agreement With Angiogene Pharma For Neuroendocrine Tumors 11
Mateon Therapeutics Files Registration Statement for Public Offering of Shares 13
Mateon Therapeutics Raises USD2.9 Million in Private Placement of Shares 14
Mateon Therapeutics Plans to Raise Funds trough Public Offering of Shares and Warrants 15
Oxigene Raises USD10 Million in Private Placement of Units 16
Oxigene Raises USD12 Million in Public Offering of Unit 18
Oxigene Completes Private Placement Of Preferred Stock For US$5.8 Million 20
Oxigene Raises USD5 Million in Private Placement of Shares 21
Oxigene Completes Private Placement Of Shares For US$1.7 Million 22
Mateon Therapeutics Inc, Key Competitors 23
Mateon Therapeutics Inc, Key Employees 24

List Of Figures

List of Figures
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mateon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mateon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Mateon Therapeutics Inc (MATN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye

USD 250 View Report

Mateon Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Mateon Therapeutics Inc Company Profile is a detailed strategic and analytical report on Mateon Therapeutics Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2019 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products

USD 750 View Report

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD)

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available